The mediator subunit MED16 transduces NRF2-Activating signals into antioxidant gene expression

Molecular and Cellular Biology

Volumn 36, Issue 3, 2016, Pages 407-420

  Sekine, Hiroki ^a,b   Okazaki, Keito ^b   Ota, Nao ^b   Shima, Hiroki ^a,c   Katoh, Yasutake ^b   Suzuki, Norio ^d   Igarashi, Kazuhiko ^a   Ito, Mitsuhiro ^e   Motohashi, Hozumi ^b   Yamamoto, Masayuki ^a,b  

^a Department of Medical Biochemistry ^*  (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN MED16; RNA POLYMERASE II; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; MED16 PROTEIN, MOUSE; MEDIATOR COMPLEX; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL LINE; CELL PROLIFERATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; LIVER; METABOLISM; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HUMANS; LIVER; MEDIATOR COMPLEX; MICE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPS; RNA POLYMERASE II; SIGNAL TRANSDUCTION;

EID: 84958054132     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00785-15     Document Type: Article

References (37)

1. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557. http://dx.doi.org/10.1016/j.molmed.2004.09.003.
2. Uruno A, Motohashi H. 2011. The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25:153-160. http://dx.doi.org/10.1016/j.niox.2011.02.007.
3. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, Biswal S. 2010. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38:5718-5734. http://dx.doi.org/10.1093/nar/gkq212.
4. Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, Xue P, Pi J, Kleeberger SR, Bell DA. 2012. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res 40:7416-7429 http://dx.doi.org/10.1093/nar/gks409.
5. Hirotsu Y, Katsuoka F, Funayama R, Nagashima T, Nishida Y, Nakayama K, Engel JD, Yamamoto M. 2012. Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res 40:10228-10239. http://dx.doi.org/10.1093/nar/gks827.
6. Malik S, Roeder RG. 2010. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11: 761-772. http://dx.doi.org/10.1038/nrg2901.
7. Allen BL, Taatjes DJ. 2015. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol 16:155-166. http://dx.doi.org/10.1038/nrm3951.
8. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76-86. http://dx.doi.org/10.1101/gad.13.1.76.
9. Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, McMahon M, Hayes JD, Itoh K, Yamamoto M. 2005. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch Biochem Biophys 433: 342-350. http://dx.doi.org/10.1016/j.abb.2004.10.012.
10. Chowdhry S, Zhang Y, McMahon M, Sutherland C, Cuadrado A, Hayes JD. 2013. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32:3765-3781. http://dx.doi.org/10.1038/onc.2012.388.
11. Katoh Y, Itoh K, Yoshida E, Miyagishi M, Fukamizu A, Yamamoto M. 2001. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6:857-868. http://dx.doi.org/10.1046/j.1365-2443.2001.00469.x.
12. Zhang J, Hosoya T, Maruyama A, Nishikawa K, Maher JM, Ohta T, Motohashi H, Fukamizu A, Shibahara S, Itoh K, Yamamoto M. 2007. Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes. Biochem J 404:459-466. http://dx.doi.org/10.1042/BJ20061611.
13. Nioi P, Nguyen T, Sherratt PJ, Pickett CB. 2005. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol 25:10895-10906. http://dx.doi.org/10.1128/MCB.25.24.10895-10906.2005.
14. Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, Naito M, Enomoto K, Watanabe S, Mak TW, Nakano T. 2004. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113: 1774-1783. http://dx.doi.org/10.1172/JCI20513.
15. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. 2006. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 339:79-88. http://dx.doi.org/10.1016/j.bbrc.2005.10.185.
16. Postic C, Magnuson MA. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26:149-150. http://dx.doi.org/10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V.
17. Sekine H, Mimura J, Oshima M, Okawa H, Kanno J, Igarashi K, Gonzalez FJ, Ikuta T, Kawajiri K, Fujii-Kuriyama Y. 2009. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharideinduced septic shock. Mol Cell Biol 29:6391-6400. http://dx.doi.org/10.1128/MCB.00337-09.
18. Maruyama A, Tsukamoto S, Nishikawa K, Yoshida A, Harada N, Motojima K, Ishii T, Nakane A, Yamamoto M, Itoh K. 2008. Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch Biochem Biophys 477:139-145. http://dx.doi.org/10.1016/j.abb.2008.06.004.
19. Malik S, Roeder RG. 2003. Isolation and functional characterization of the TRAP/mediator complex. Methods Enzymol 364:257-284. http://dx.doi.org/10.1016/S0076-6879(03)64015-2.
20. Kim S, Xu X, Hecht A, Boyer TG. 2006. Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem 281:14066-14075. http://dx.doi.org/10.1074/jbc.M602696200.
21. Lawrence AM, Besir HU. 2009. Staining of proteins in gels with Coomassie G-250 without organic solvent and acetic acid. J Vis Exp 30:e1350. http://dx.doi.org/10.3791/1350.
22. Kalli A, Smith GT, Sweredoski MJ, Hess S. 2013. Evaluation and optimization of mass spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass analyzers. J Proteome Res 12: 3071-3086. http://dx.doi.org/10.1021/pr3011588.
23. Stasevich TJ, Hayashi-Takanaka Y, Sato Y, Maehara K, Ohkawa Y, Sakata-Sogawa K, Tokunaga M, Nagase T, Nozaki N, McNally JG, Kimura H. 2014. Regulation of RNA polymerase II activation by histone acetylation in single living cells. Nature 516:272-275. http://dx.doi.org/10.1038/nature13714.
24. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S. 2008. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A 105:13568-13573. http://dx.doi.org/10.1073/pnas.0806268105.
25. Ito M, Okano HJ, Darnell RB, Roeder RG. 2002. The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J 21:3464-3475. http://dx.doi.org/10.1093/emboj/cdf348.
26. Stevens JL, Cantin GT, Wang G, Shevchenko A, Berk AJ. 2002. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 296:755-758. http://dx.doi.org/10.1126/science.1068943.
27. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. +2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell +154:1370-1379.http://dx.doi.org/10.1016/j.cell.2013.08.022.
28. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H. 2012. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22:66-79. http://dx.doi.org/10.1016/j.ccr.2012.05.016.
29. Taguchi K, Hirano I, Itoh T, Tanaka M, Miyajima A, Suzuki A, Motohashi H, Yamamoto M. 2014. Nrf2 enhances cholangiocyte expansion in Pten-deficient livers. Mol Cell Biol 34:900-913. http://dx.doi.org/10.1128/MCB.01384-13.
30. Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763. http://dx.doi.org/10.1016/S0092-8674(03)00934-6.
31. Sharma D, Fondell JD. 2002. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci U S A 99:7934-7939. http://dx.doi.org/10.1073/pnas.122004799.
32. Buratowski S. 2009. Progression through the RNA polymerase II CTD cycle. Mol Cell 36:541-546. http://dx.doi.org/10.1016/j.molcel.2009.10.019.
33. Egloff S, Dienstbier M, Murphy S. 2012. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet 28:333-341. http://dx.doi.org/10.1016/j.tig.2012.03.007.
34. Kim TW, Kwon YJ, Kim JM, Song YH, Kim SN, Kim YJ. +2004. MED16 and MED23 of Mediator are coactivators of lipopolysaccharide-and heatshock- induced transcriptional activators. Proc Natl Acad Sci U S A +101: 12153-12158. http://dx.doi.org/10.1073/pnas.0401985101.
35. Galbraith MD, Allen MA, Bensard CL, Wang X, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD, Espinosa JM. 2013. HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell 153:1327-1339. http://dx.doi.org/10.1016/j.cell.2013.04.048.
36. Beischlag TV, Taylor RT, Rose DW, Yoon D, Chen Y, Lee WH, Rosenfeld MG, Hankinson O. 2004. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. J Biol Chem 279:54620-54628. http://dx.doi.org/10.1074/jbc.M410456200.
37. Ando R, Shima H, Tamahara T, Sato Y, Watabane-Matsui M, Kato H, Sax N, Motohashi H, Taguchi K, Yamamoto M, Nio M, Maeda T, Ochiai K, Muto A, Igarashi K. The transcription factor Bach2 is phosphorylated at mutiple sites in murine B cells but a single site prevents its nuclear localization. J Biol Chem, in press. http://dx.doi.org/10.1074/jbc.M115.661702.